Transcriptomics

Dataset Information

0

Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD19+ cells, exon level]

ABSTRACT: We analyzed the gene expression patterns of different blood cell types before and during fingolimod treatment in a group of patients with relapsing-remitting multiple sclerosis (RRMS). Affymetrix Human Transcriptome Arrays (HTA) 2.0 were used to obtain gene expression profiles of immune cell populations from 10 RRMS patients within the first 3 months of fingolimod treatment. This GEO entry provides the Affymetrix HTA 2.0 microarray data of peripheral blood CD19+ cells, preprocessed according to the exon level workflow.

ORGANISM(S): Homo sapiens

PROVIDER: GSE81606 | GEO | 2016/05/20

SECONDARY ACCESSION(S): PRJNA322149

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD56+ cells, exon level]
2016-05-20 | GSE81611 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD4+ cells, gene level]
2015-09-19 | GSE73079 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD8+ cells, exon level]
2015-09-19 | GSE73172 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD8+ cells, gene level]
2015-09-19 | GSE73081 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD19+ cells, gene level]
2016-05-20 | GSE81604 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD14+ cells, gene level]
2016-05-20 | GSE81598 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD4+ cells, exon level]
2015-09-19 | GSE73080 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD56+ cells, gene level]
2016-05-20 | GSE81607 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD14+ cells, exon level]
2016-05-20 | GSE81603 | GEO
Transcriptomics Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD4+ cells, gene level]
2015-09-19 | E-GEOD-73079 | biostudies-arrayexpress